Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis

dc.contributor.author	Wedemeyer, Heiner
dc.date.accessioned	2020-02-17T09:25:01Z
dc.date.available	2020-02-17T09:25:01Z
dc.date.issued	2018
dc.identifier.issn	1365-2036
dc.identifier.uri	http://hdl.handle.net/10900/98061
dc.language.iso	en	de_DE
dc.publisher	Wiley	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/apt.14427	de_DE
dc.subject.ddc	610	de_DE
dc.title	Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190321153956_03935
utue.publikation.seiten	516-525	de_DE
utue.personen.roh	Mettke, F.
utue.personen.roh	Schlevogt, B.
utue.personen.roh	Deterding, K.
utue.personen.roh	Wranke, A.
utue.personen.roh	Smith, A.
utue.personen.roh	Port, K.
utue.personen.roh	Manns, M. P.
utue.personen.roh	Vogel, A.
utue.personen.roh	Cornberg, M.
utue.personen.roh	Wedemeyer, H.
dcterms.isPartOf.ZSTitelID	Alimentary Pharmacology & Therapeutics	de_DE
dcterms.isPartOf.ZS-Issue	4	de_DE
dcterms.isPartOf.ZS-Volume	47	de_DE